{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "aptamer-protein free energy calculation",
      "aptamer-protein interaction",
      "aptamers virtual screening",
      "prediction of 3D RNA aptamer structure",
      "single strand RNA aptamer"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34206794",
  "DateCompleted": {
    "Year": "2021",
    "Month": "07",
    "Day": "08"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "06",
        "Day": "26"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "6874",
      "10.3390/ijms22136874"
    ],
    "Journal": {
      "ISSN": "1422-0067",
      "JournalIssue": {
        "Volume": "22",
        "Issue": "13",
        "PubDate": {
          "Year": "2021",
          "Month": "Jun",
          "Day": "26"
        }
      },
      "Title": "International journal of molecular sciences",
      "ISOAbbreviation": "Int J Mol Sci"
    },
    "ArticleTitle": "<i>De novo</i> ssRNA Aptamers against the SARS-CoV-2 Main Protease: In Silico Design and Molecular Dynamics Simulation.",
    "Abstract": {
      "AbstractText": [
        "Herein, we have generated ssRNA aptamers to inhibit SARS-CoV-2 M<sup>pro</sup>, a protease necessary for the SARS-CoV-2 coronavirus replication. Because there is no aptamer 3D structure currently available in the databanks for this protein, first, we modeled an ssRNA aptamer using an entropic fragment-based strategy. We refined the initial sequence and 3D structure by using two sequential approaches, consisting of an elitist genetic algorithm and an RNA inverse process. We identified three specific aptamers against SARS-CoV-2 M<sup>pro</sup>, called MApta<sup>pro</sup>, MApta<sup>pro</sup>-IR1, and MApta<sup>pro</sup>-IR2, with similar 3D conformations and that fall in the dimerization region of the SARS-CoV-2 M<sup>pro</sup> necessary for the enzymatic activity. Through the molecular dynamic simulation and binding free energy calculation, the interaction between the MApta<sup>pro</sup>-IR1 aptamer and the SARS-CoV-2 M<sup>pro</sup> enzyme resulted in the strongest and the highest stable complex; therefore, the ssRNA MApta<sup>pro</sup>-IR1 aptamer was selected as the best potential candidate for the inhibition of SARS-CoV-2 M<sup>pro</sup> and a perspective therapeutic drug for the COVID-19 disease."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Chemistry, Biology and Biotechnology, University of Perugia, Via del Giochetto, 06123 Perugia, Italy."
          }
        ],
        "LastName": "Morena",
        "ForeName": "Francesco",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Chemistry, Biology and Biotechnology, University of Perugia, Via del Giochetto, 06123 Perugia, Italy."
          }
        ],
        "LastName": "Argentati",
        "ForeName": "Chiara",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Chemistry, Biology and Biotechnology, University of Perugia, Via del Giochetto, 06123 Perugia, Italy."
          }
        ],
        "LastName": "Tortorella",
        "ForeName": "Ilaria",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Chemistry, Biology and Biotechnology, University of Perugia, Via del Giochetto, 06123 Perugia, Italy."
          },
          {
            "Identifier": [],
            "Affiliation": "Centro di Eccellenza CEMIN (Materiali Innovativi Nanostrutturali per Applicazioni Chimica Fisiche e Biomediche), University of Perugia, 06123 Perugia, Italy."
          }
        ],
        "LastName": "Emiliani",
        "ForeName": "Carla",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Chemistry, Biology and Biotechnology, University of Perugia, Via del Giochetto, 06123 Perugia, Italy."
          },
          {
            "Identifier": [],
            "Affiliation": "Centro di Eccellenza CEMIN (Materiali Innovativi Nanostrutturali per Applicazioni Chimica Fisiche e Biomediche), University of Perugia, 06123 Perugia, Italy."
          }
        ],
        "LastName": "Martino",
        "ForeName": "Sabata",
        "Initials": "S"
      }
    ],
    "GrantList": [
      {
        "GrantID": "220.0513",
        "Agency": "Fondazione Cassa di Risparmio di Perugia",
        "Country": ""
      },
      {
        "GrantID": "Google Cloud COVID-19 Credits Program",
        "Agency": "Google",
        "Country": ""
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Int J Mol Sci",
    "NlmUniqueID": "101092791",
    "ISSNLinking": "1422-0067"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Aptamers, Nucleotide"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "DNA, Single-Stranded"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Viral Matrix Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "membrane protein, SARS-CoV-2"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "chemistry",
        "metabolism"
      ],
      "DescriptorName": "Aptamers, Nucleotide"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Binding Sites"
    },
    {
      "QualifierName": [
        "pathology",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "chemistry"
      ],
      "DescriptorName": "DNA, Single-Stranded"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Design"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Entropy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Hydrogen Bonding"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Docking Simulation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Dynamics Simulation"
    },
    {
      "QualifierName": [
        "isolation & purification",
        "metabolism"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "chemistry",
        "metabolism"
      ],
      "DescriptorName": "Viral Matrix Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ],
  "CoiStatement": "The authors declare no conflict of interest."
}